Vanguard Group’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

Vanguard Group’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-23,239	Closed	-$184K	–	4452
2024 Q1	$184K	Hold	23,239	–	–	﹤0.01%	4191
2023 Q4	$167K	Sell	23,239 -494	-2%	-$5.49K	﹤0.01%	4243
2023 Q3	$444K	Hold	23,733	–	–	﹤0.01%	4088
2023 Q2	$675K	Hold	23,733	–	–	﹤0.01%	4028
2023 Q1	$1.32M	Buy	23,733 +941	+4%	+$33.3K	﹤0.01%	3828
2022 Q4	$492K	Buy	22,792 +9	+0%	+$245	﹤0.01%	4103
2022 Q3	$681K	Buy	22,783 +5,041	+28%	+$177K	﹤0.01%	4126
2022 Q2	$575K	Sell	17,742 -2,363	-12%	-$163K	﹤0.01%	4255
2022 Q1	$1.94M	Buy	20,105 +2,610	+15%	+$396K	﹤0.01%	3972
2021 Q4	$3.4M	Sell	17,495 -6,306	-26%	-$982K	﹤0.01%	3818
2021 Q3	$4.77M	Buy	23,801 +21,023	+757%	+$5.34M	﹤0.01%	3695
2021 Q2	$1.1M	Buy	+2,778	New	+$982K	﹤0.01%	4132

Other funds holding TBIO

Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

DWS

Dynamic Wealth Strategies Granite Bay, California $188M AUM 18.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Vanguard Group's TBIO Position: Q2 2024 in Review

Vanguard Group sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q2 2024, closing a stake of 23,239 shares — an estimated $184K sold.

Vanguard Group first reported a position in TBIO in Q2 2021 and held it in 12 quarters. The position peaked at $4.77M in Q3 2021. 10 funds tracked by Wall St. Rank hold TBIO as of Q2 2024.

Vanguard Group reported no remaining Telesis Bio, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Vanguard Group sold 23,239 Telesis Bio, Inc. Common Stock shares in Q2 2024, an estimated $184K.
Vanguard Group first reported a position in Telesis Bio, Inc. Common Stock in Q2 2021 and held it in 12 quarters.
Vanguard Group's Telesis Bio, Inc. Common Stock position peaked at $4.77M in Q3 2021.
10 funds tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q2 2024.

Based on Vanguard Group's 13F filing for Q2 2024, filed 13 Aug 2024.